Identifying the Axillary Substructure at Risk for Lymphedema in Operable Patients With Breast Cancer Receiving Regional Nodal Irradiation

医学 淋巴水肿 乳腺癌 放射科 放射治疗 下部结构 腋窝 节的 乳腺摄影术 辐射剂量 癌症 肿瘤科 外科 风险评估 辐照 核医学 梅德林 乳房切除术 内科学
作者
J Y Huang,Siyue Zheng,Maochen Zhang,Shujun Zhang,Jing-Jing Cao,Kun-wei Shen,wei-xiang Qi,Gang Cai,Lu Cao,Jiayi Chen
出处
期刊:Practical radiation oncology [Elsevier BV]
卷期号:16 (2): e90-e100 被引量:2
标识
DOI:10.1016/j.prro.2025.12.003
摘要

Purpose Axillary substructures may contribute to the development of breast cancer-related lymphedema (BCRL). This study aimed to compare dose-volume parameters of various substructures to identify high-risk regions associated with BCRL and to evaluate the clinical applicability of these findings. Methods and Materials Cohort-Initial included 336 patients with pT1-3N0-1M0 breast cancer who underwent mastectomy or lumpectomy with axillary lymph node dissection (ALND) and regional nodal irradiation (RNI) between August 2018 and February 2021. The Norman questionnaire was used to assess BCRL. Thirteen dose-volume parameters across 8 axillary substructures were assessed for association with BCRL. Cohort-Recurrence comprised 50 consecutive ALND-treated patients with regional nodal recurrence diagnosed using positron emission tomography/computed tomography, used to evaluate the recurrence risk in the candidate substructures. Cohort-Reoptimization involved 20 patients from the Cohort-Initial who received excessive radiation doses in the candidate substructure. Their treatment plans were reoptimized to assess the feasibility of dose reduction while maintaining target coverage and organ dose. Results The patient-reported cumulative incidence of BCRL was 33.9% during a median follow-up of 60 months. Significant baseline risk factors included body mass index ≥ 27.18 kg/m 2 , tumor size ≥ 1.9 cm, premenopausal status, and ≥ 18 lymph nodes removed (all P < .05). The most significant dosimetric parameter was axillary-lateral thoracic vessel juncture (ALTJ)-V35 Gy ≥ 79.2%. A predictive nomogram incorporating these clinicopathologic factors and the ALTJ parameter was developed with reasonable accuracy, as confirmed by self-training (area under the curve value, 0.780) and internal validation (area under the curve value, 0.769). None of the 196 fluorodeoxyglucose-avid regional nodes in Cohort-Recurrence were located within the ALTJ. Reoptimization of ALTJ-V35 Gy was feasible without compromising the radiation therapy plan quality. Conclusions ALTJ-V35 Gy < 79.2% may serve as a recommended dose constraint for patients undergoing RNI after ALND. Avoiding excessive radiation to the ALTJ is clinically feasible and safe, potentially mitigating BCRL risk without compromising dose coverage to high-risk nodal regions.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
裴成风完成签到,获得积分10
刚刚
cdercder的应助被简单点采纳,获得10
刚刚
救救孩子吧完成签到,获得积分10
刚刚
1秒前
1秒前
1秒前
mantou发布了新的文献求助10
1秒前
MZH完成签到 ,获得积分10
1秒前
自由完成签到 ,获得积分10
1秒前
1秒前
2秒前
山山而川发布了新的文献求助10
2秒前
mgqqlwq发布了新的文献求助10
2秒前
七树鱼完成签到,获得积分10
2秒前
tutu发布了新的文献求助10
3秒前
Maestro_S的应助被单纯的皮卡丘采纳,获得30
3秒前
有何不可完成签到,获得积分10
3秒前
liuz53完成签到,获得积分10
3秒前
bnjb完成签到,获得积分10
3秒前
4秒前
大力的康乃馨完成签到 ,获得积分10
4秒前
4秒前
NexusExplorer的应助被zttszds采纳,获得10
4秒前
rd_z完成签到,获得积分10
4秒前
5秒前
5秒前
刘柑橘完成签到,获得积分10
5秒前
香蕉觅云的应助被Bigwang采纳,获得10
6秒前
zzz完成签到,获得积分10
6秒前
Hoo完成签到,获得积分10
7秒前
Maestro_S的应助被bnjb采纳,获得10
7秒前
饭团发布了新的文献求助10
7秒前
xxx完成签到,获得积分10
7秒前
7秒前
han发布了新的文献求助10
9秒前
王肖发布了新的文献求助10
9秒前
赘婿的应助被小小欢乐魔法师采纳,获得10
9秒前
10秒前
mgqqlwq完成签到,获得积分10
10秒前
勺子爱西瓜完成签到,获得积分0
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153442
求助须知:如何正确求助?哪些是违规求助? 9550127
关于积分的说明 21696715
捐赠科研通 7741908
什么是DOI,文献DOI怎么找? 3425483
关于科研通互助平台的介绍 2550608
邀请新用户注册赠送积分活动 2469152